Advanced 2D-LC/MS Workflow for the Characterization of Semaglutide and Its Impurities

Applications | 2025 | Agilent TechnologiesInstrumentation
LC/MS, LC/MS/MS, LC/HRMS, LC/TOF, 2D-LC
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Complete Analytical Workflows for GLP-1 Receptor Agonists
Complete Analytical Workflows for GLP-1 Receptor Agonists
2025|Agilent Technologies|Brochures and specifications
Advanced Characterization of Semaglutideand Its Impurities Using a Heart-Cutting 2D-LC/MS Workflow for Biopharmaceutical Analysis
LC/MS Based Characterization Workflow of GLP-1 Therapeutic Peptide Liraglutide and Its Impurities
Comprehensive characterization of oligonucleotides and related impurities using advanced LC/Q-TOF analytical workflows